GlassScriptPhysician profile
Dennis M Murphy
NPI 1992704522
$1,625.06
in general payments reported to CMS, 2019-2025
26 companies · $202 in 2025
The $202 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.42 · 2020: $15.76 · 2021: $589 · 2022: $348 · 2023: $180 · 2024: $248 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $629.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $255.51 | 2021-2025 | Spinal-Stim, Spinal-Stim, Cervical-Stim |
| Astrazeneca Pharmaceuticals LP | $176.07 | 2022-2024 | Andexxa |
| Stryker Corporation | $169.58 | 2021-2022 | |
| Radius Health, INC. | $167.78 | 2021 | |
| Lemaitre Vascular, INC. | $122.82 | 2022-2024 | Anastoclip Gc 8cm (Medium) |
| Zimmer Biomet Holdings, INC. | $104.93 | 2019-2023 | Thinflap |
| Depuy Synthes Sales INC. | $101.47 | 2019-2021 | |
| Nevro Corp. | $75.32 | 2023-2024 | Senza |
| Bioventus LLC | $55.41 | 2022-2025 | Bonescalpel & Sonicone (O.R.) |
| Microtransponder, INC. | $53.14 | 2025 | |
| Servier Pharmaceuticals LLC | $45.15 | 2024 | |
| Integra Lifesciences Corporation | $31.58 | 2024 | Microfrance, Instruments-Orthopedic, Codman Isocool Aht |
| Baxter Healthcare | $28.00 | 2022 | |
| Ebi, LLC | $24.41 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Vertex Pharmaceuticals Incorporated | $24.40 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $22.52 | 2025 | General - Pain Management |
| Merck Sharp & Dohme LLC | $21.50 | 2022 | |
| Reel Surgical, INC. | $18.43 | 2025 | |
| Novocure INC. | $17.44 | 2024 | Optune |
| Smith+Nephew, INC. | $16.24 | 2022 | |
| Zimvie INC. | $16.15 | 2022 | |
| Theragen, INC. | $16.00 | 2025 | Actastim-S |
| Arteriocyte Medical Systems, INC. | $15.83 | 2022 | |
| Portola Pharmaceuticals, LLC | $15.76 | 2020 | |
| Heron Therapeutics, INC. | $14.93 | 2024 | Zynrelef |
| Medtronic, INC. | $14.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.